iFLYHealth - Public Comps and Valuation Multiples

iFLYHealth Overview

About iFLYHealth

Xunfei Healthcare Technology Co Ltd is an AI-empowered healthcare solution provider, offering products and solutions that support a range of healthcare services, ranging from health risk warnings, early screening, auxiliary diagnosis and treatment, as well as treatment effect evaluation, to post-discharge management and chronic disease management. It has independently developed AI technologies that underpin its products and solutions. Smart Healthcare, Smart Hospital, Intelligent Hardware, Smart Medical Insurance, and Smart Imaging Union. The Company’s revenue was mainly derived from PHC services and patient services.

Founded

2021

HQ

Employees

911

Website

xunfeihealthcare.com

Sectors

Healthcare Software
Vertical AI Applications
HealthTech
DeepTech

Financials

LTM Revenue $140M

LTM EBITDA -$4.8M

EV

$1.3B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

iFLYHealth Financials

As of September 2025, iFLYHealth reported last 12-month revenue of $140M and EBITDA of -$4.8M.

In the same period, iFLYHealth generated $76.2M in LTM gross profit and -$11.7M in net income.

See iFLYHealth valuation multiples based on analyst estimates

iFLYHealth P&L

In the most recent fiscal year, iFLYHealth reported revenue of $94.3M and EBITDA of -$15.2M.

iFLYHealth expects next 12-month revenue of XXX and NTM EBITDA of XXX

See iFLYHealth valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$140M	XXX	$94.3M	XXX	XXX	XXX
Gross Profit	$76.2M	XXX	$51.9M	XXX	XXX	XXX
Gross Margin	54%	XXX	55%	XXX	XXX	XXX
EBITDA	-$4.8M	XXX	-$15.2M	XXX	XXX	XXX
EBITDA Margin	-3%	XXX	-16%	XXX	XXX	XXX
EBIT	-$25.4M	XXX	-$15.5M	XXX	XXX	XXX
EBIT Margin	-18%	XXX	-16%	XXX	XXX	XXX
Net Profit	-$11.7M	XXX	-$17.0M	XXX	XXX	XXX
Net Margin	-8%	XXX	-18%	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for iFLYHealth including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $140M. EBITDA for the last twelve months was -$4.8M. In the most recent fiscal year, iFLYHealth achieved $94.3M in revenue and -$15.2M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$140M	Analyst estimates available to subscribers	$94.3M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$76.2M	Analyst estimates available to subscribers	$51.9M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	54.3% gross margin	Analyst estimates available to subscribers	55.1% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	-$4.8M	Analyst estimates available to subscribers	-$15.2M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	-3.4% EBITDA margin	Analyst estimates available to subscribers	-16.1% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	-$25.4M	Analyst estimates available to subscribers	-$15.5M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	-18.1% EBIT margin	Analyst estimates available to subscribers	-16.5% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	-$11.7M	Analyst estimates available to subscribers	-$17.0M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	-8.3% net profit margin	Analyst estimates available to subscribers	-18.1% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for iFLYHealth

This financial data table provides comprehensive performance metrics for iFLYHealth, a company based in Hong Kong. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

iFLYHealth generated $140M in revenue over the last twelve months.
The company achieved -$4.8M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $76.2M.
Net income over the last twelve months reached -$11.7M.

Fiscal Year Performance

In the most recent fiscal year, iFLYHealth reported $94.3M in total revenue.
Fiscal year EBITDA was -$15.2M.
The company maintained a gross profit margin of 55.1% in the most recent fiscal year.
EBITDA margin for the fiscal year was -16.1%.
Net profit margin reached -18.1% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for iFLYHealth. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

iFLYHealth Stock Performance

iFLYHealth has current market cap of HKD 10.6B (or $1.4B), and EV of HKD 10.4B (or $1.3B).

Market Cap Evolution

iFLYHealth Stock Data

As of October 17, 2025, iFLYHealth's stock price is HKD 88 (or $11).

See iFLYHealth trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$1.3B	$1.4B	XXX	XXX	XXX	XXX	$-0.05

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

iFLYHealth Valuation Multiples

iFLYHealth's trades at 14.2x EV/Revenue multiple, and -88.2x EV/EBITDA.

See valuation multiples for iFLYHealth and 15K+ public comps

iFLYHealth Financial Valuation Multiples

As of October 17, 2025, iFLYHealth has market cap of $1.4B and EV of $1.3B.

Equity research analysts estimate iFLYHealth's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

iFLYHealth has a P/E ratio of -127.6x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$1.4B	XXX	$1.4B	XXX	XXX	XXX
EV (current)	$1.3B	XXX	$1.3B	XXX	XXX	XXX
EV/Revenue	10.4x	XXX	14.2x	XXX	XXX	XXX
EV/EBITDA	-305.2x	XXX	-88.2x	XXX	XXX	XXX
EV/EBIT	-57.5x	XXX	-86.0x	XXX	XXX	XXX
EV/Gross Profit	19.2x	XXX	n/a	XXX	XXX	XXX
P/E	-127.6x	XXX	-80.3x	XXX	XXX	XXX
EV/FCF	n/a	XXX	-62.2x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get iFLYHealth Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

iFLYHealth Margins & Growth Rates

iFLYHealth's last 12 month revenue growth is 30%

iFLYHealth's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.

iFLYHealth's rule of 40 is 4% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

iFLYHealth's rule of X is 72% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for iFLYHealth and other 15K+ public comps

iFLYHealth Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	30%	XXX	36%	XXX	XXX	XXX
EBITDA Margin	-3%	XXX	-16%	XXX	XXX	XXX
EBITDA Growth	-266%	XXX	n/a	XXX	XXX	XXX
Rule of 40	4%	XXX	14%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	72%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.1M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.1M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	26%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	37%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	72%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial